electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025
electroCore (NASDAQ: ECOR), a bioelectronic medicine and wellness company, has scheduled its Q2 2025 financial results announcement for Wednesday, August 6, 2025, after market close.
The company will host an interactive webinar at 4:30 PM EDT where management will review financial results and take questions from participants. Investors can join using the dial-in number (646) 931-3860, with Webinar ID 843 8084 9004 and Passcode 049555.
electroCore (NASDAQ: ECOR), azienda specializzata in medicina bioelettronica e benessere, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per mercoledì 6 agosto 2025, dopo la chiusura del mercato.
L'azienda terrà un webinar interattivo alle 16:30 EDT, durante il quale il management illustrerà i risultati finanziari e risponderà alle domande dei partecipanti. Gli investitori potranno partecipare chiamando il numero (646) 931-3860, utilizzando il Webinar ID 843 8084 9004 e il codice di accesso 049555.
electroCore (NASDAQ: ECOR), una empresa de medicina bioelectrónica y bienestar, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el miércoles 6 de agosto de 2025, después del cierre del mercado.
La compañía realizará un seminario web interactivo a las 4:30 PM EDT, donde la dirección revisará los resultados financieros y responderá preguntas de los participantes. Los inversores pueden unirse llamando al número (646) 931-3860, con el ID del seminario web 843 8084 9004 y la contraseña 049555.
electroCore (NASDAQ: ECOR)는 바이오일렉트로닉 의학 및 웰니스 회사로, 2025년 2분기 재무실적 발표를 2025년 8월 6일 수요일 장 마감 후에 예정하고 있습니다.
회사는 동부표준시 오후 4:30에 인터랙티브 웨비나를 개최하여 경영진이 재무실적을 검토하고 참가자들의 질문에 답변할 예정입니다. 투자자들은 전화번호 (646) 931-3860, 웨비나 ID 843 8084 9004, 비밀번호 049555를 통해 참여할 수 있습니다.
electroCore (NASDAQ: ECOR), une entreprise de médecine bioélectronique et de bien-être, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le mercredi 6 août 2025, après la clôture du marché.
L'entreprise organisera un webinaire interactif à 16h30 EDT où la direction présentera les résultats financiers et répondra aux questions des participants. Les investisseurs peuvent se joindre en composant le numéro (646) 931-3860, avec l'ID du webinaire 843 8084 9004 et le code d'accès 049555.
electroCore (NASDAQ: ECOR), ein Unternehmen für bioelektronische Medizin und Wellness, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Mittwoch, den 6. August 2025, nach Börsenschluss angekündigt.
Das Unternehmen wird um 16:30 Uhr EDT ein interaktives Webinar veranstalten, bei dem das Management die Finanzergebnisse erläutert und Fragen der Teilnehmer beantwortet. Investoren können sich unter der Telefonnummer (646) 931-3860 mit der Webinar-ID 843 8084 9004 und dem Zugangscode 049555 einwählen.
- None.
- None.
ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2025, after the close of the market on Wednesday, August 6, 2025.
Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:
Wednesday, August 6, 4:30 PM EDT
Dial-In: (646) 931-3860
Webinar ID: 843 8084 9004
Passcode: 049555
Registration Link: Click here to participate and ask questions on the call.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator. Additionally, the company commercializes its Truvaga products, handheld, and personal use nVNS products utilizing bioelectronic technologies, to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When will electroCore (ECOR) report Q2 2025 earnings?
How can investors join electroCore's Q2 2025 earnings call?
What period will electroCore's upcoming earnings report cover?
What type of company is electroCore (ECOR)?
